Eric Kim interviews Aaron Berger about treatment approaches for high-risk prostate cancer and biochemical recurrence. Dr. Berger explains his balanced approach to treatment selection between surgery ...

Sam Chang interviews Alice Yu about three practice-changing areas in urothelial carcinoma. Dr. Yu first discusses the NIAGARA trial, which demonstrated improved pathologic complete response, ...

Ashish Kamat interviews Patrick Soon-Shiong about expanding ANKTIVA® (NAI) indications to include papillary-only BCG-unresponsive bladder cancer. Dr. Soon-Shiong highlights three-year data showing 82% ...

ASCO 2025 Press Releases Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ...

There are other non-infectious IUC-related adverse effects that occur the longer an indwelling urinary catheter (IUC), particularly a transurethral IUC, is used for bladder drainage. They include ...

(UroToday.com) The 2025 AUA annual meeting featured a prostate cancer session and a presentation by Dr. Madison Krischak discussing access to prostate cancer clinical trials in the VA and whether ...

(UroToday.com) The American Urological Association's 2025 Annual Meeting, between April 26 – 29, 2025 in Las Vegas, Nevada, was host to the Plenary Session on Saturday 26 th of April. Drs. Lara ...

(UroToday.com) The American Urologic Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, between April 26 th and 29 th, 2025, was host to an advanced kidney cancer moderated poster session.

(UroToday.com) The 2025 AUA annual meeting featured a prostate cancer session and a presentation by Dr. Gal Wald discussing a multicenter comparison of retzius-sparing, hood, and standard techniques ...

(UroToday.com) The American Urological Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, was host to an advanced prostate cancer moderated poster session. Dr. Armando Stabile presented a ...

(UroToday.com) The 2025 AUA annual meeting featured an upper tract urothelial carcinoma session and a presentation by Dr. Jiwei Huang discussing results of a phase II study of tislelizumab as ...

(UroToday.com) The American Urological Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, was host to The International Prostate Forum. Dr. R. Jonathan Henderson provided a focused, ...